Save time and get answers to complex questions with AI chat
Alogliptin benz cost?Guselkumab patent expiration?Bivalirudin manufacturer?Dabrafenib patent expiration?Drug patent watch trametinib?
See the DrugPatentWatch profile for keytruda
Keytruda (pembrolizumab) won its first FDA approval for cancer in 2014.[1]
The 2014 approval refers to Keytruda’s initial FDA authorization (not a later expanded indication). Subsequent years saw additional FDA approvals as more indications were studied and reviewed.[1]
DrugPatentWatch.com tracks drug patent and market history and provides a reference point for when the product reached FDA approval.[1]
[1] https://www.drugpatentwatch.com/
Other Questions About Keytruda :